CADASIL and CARASIL

por Tikka, Saara, Baumann, Marc, Siitonen, Maija, Pasanen, Petra, Pöyhönen, Minna, Myllykangas, Liisa, Viitanen, Matti, Fukutake, Toshio, Cognat, Emmanuel, Joutel, Anne, Kalimo, Hannu
Publicado 2014

P362: OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING HEMATOPOIETIC CELL TRANSPLANTATION USING REAL-WORLD DATA FROM HARMONY

por Russell-Smith, Alexander, Taiji, Riley, Tétreault-Langlois, Paule, Gallienne, Samy, Ionescu-Ittu, Raluca, Vekeman, Francis, Moorman, Anthony, Doubek, Michael, Tikka, Saara, Turki, Amin
Publicado 2023

Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients

por Tikka, Saara, Mykkänen, Kati, Ruchoux, Marie-Magdeleine, Bergholm, Robert, Junna, Maija, Pöyhönen, Minna, Yki-Järvinen, Hannele, Joutel, Anne, Viitanen, Matti, Baumann, Marc, Kalimo, Hannu
Publicado 2009

CADASIL mutations and shRNA silencing of NOTCH3 affect actin organization in cultured vascular smooth muscle cells

por Tikka, Saara, Peng Ng, Yan, Di Maio, Giuseppe, Mykkänen, Kati, Siitonen, Maija, Lepikhova, Tatiana, Pöyhönen, Minna, Viitanen, Matti, Virtanen, Ismo, Kalimo, Hannu, Baumann, Marc
Publicado 2012

Differences in proliferation rate between CADASIL and control vascular smooth muscle cells are related to increased TGFβ expression

por Panahi, Mahmod, Yousefi Mesri, Naeimeh, Samuelsson, Eva‐Britt, Coupland, Kirsten G., Forsell, Charlotte, Graff, Caroline, Tikka, Saara, Winblad, Bengt, Viitanen, Matti, Karlström, Helena, Sundström, Erik, Behbahani, Homira
Publicado 2018

P376: VENO-OCCLUSIVE DISEASE RISK AND OTHER OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC...

por de Lima, Marcos, Kebriaei, Partow, Lanza, Francesco, Cho, Christina, Popradi, Gizelle, Kaur, Manmeet, Zhang, Mei-Jie, Zhang, Fan, Tikka, Saara, Vandendries, Erik, Asomaning, Kofi, Dorman, Stephanie, Stelljes, Matthias, Marks, David, Saber, Wael
Publicado 2023